DrugId:  1
1. Name:  5-fluoro-2'-deoxycytidine
2. Groups:  Investigational
3. Description:  5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.
4. Indication:  Not Available
DrugId:  2
1. Name:  APR-246
2. Groups:  Investigational
3. Description:  APR-246 has been used in trials studying the treatment of Prostatic Neoplasms, Hematologic Neoplasms, and Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53.
4. Indication:  Not Available
DrugId:  3
1. Name:  Tetrahydrouridine
2. Groups:  Investigational
3. Description:  Tetrahydrouridine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Sickle Cell Disease, and Head and Neck Cancer, among others.
4. Indication:  Not Available
DrugId:  4
1. Name:  CP-547632
2. Groups:  Investigational
3. Description:  CP-547632 has been used in trials studying the treatment of Ovarian Cancer, Lung Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, and Fallopian Tube Cancer, among others.
4. Indication:  Not Available
DrugId:  5
1. Name:  MK-1496
2. Groups:  Investigational
3. Description:  MK-1496 has been used in trials studying the treatment of Neoplasms and Malignant.
4. Indication:  Not Available
DrugId:  6
1. Name:  Ombrabulin
2. Groups:  Investigational
3. Description:  Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.
4. Indication:  Not Available
DrugId:  7
1. Name:  PF-04217903
2. Groups:  Investigational
3. Description:  PF-04217903 has been used in trials studying the treatment of Neoplasms.
4. Indication:  Not Available
DrugId:  8
1. Name:  MK-8776
2. Groups:  Investigational
3. Description:  Sch 900776 has been used in trials studying the treatment of Neoplasms, Hodgkin Disease, Adult Erythroleukemia, Lymphoma, Non-Hodgkin, and Myelogenous Leukemia, Acute, among others.
4. Indication:  Not Available
DrugId:  9
1. Name:  Galunisertib
2. Groups:  Investigational
3. Description:  Galunisertib has been used in trials studying the basic science and treatment of Glioma, Neoplasms, Solid Tumor, GLIOBLASTOMA, and Prostate Cancer, among others.
4. Indication:  Not Available
DrugId:  10
1. Name:  Apaziquone
2. Groups:  Investigational
3. Description:  Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.
4. Indication:  Not Available
DrugId:  11
1. Name:  BCG vaccine
2. Groups:  Investigational
3. Description:  BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  12
1. Name:  Berzosertib
2. Groups:  Investigational
3. Description:  Berzosertib (VX-970) has been used in trials studying the treatment of Ovarian Neoplasms, Ovarian Serous Tumor, Adult Solid Neoplasm, Advanced Solid Tumor, and Advanced Solid Neoplasm, among others.
4. Indication:  Not Available
DrugId:  13
1. Name:  CPG-52852
2. Groups:  Investigational
3. Description:  852A has been used in trials studying the treatment of Melanoma, Neoplasms, Breast Cancer, Ovarian Cancer, and Cervical Cancer, among others.
4. Indication:  Not Available
DrugId:  14
1. Name:  Daniquidone
2. Groups:  Investigational
3. Description:  Daniquidone has been used in trials studying the treatment of Neoplasms.
4. Indication:  Not Available
DrugId:  15
1. Name:  PF-04691502
2. Groups:  Investigational
3. Description:  PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
4. Indication:  Not Available
DrugId:  16
1. Name:  Enfortumab vedotin
2. Groups:  Investigational
3. Description:  Enfortumab vedotin has been used in trials studying the treatment of Tumors, Neoplasms, and Medical Oncology.
4. Indication:  Not Available
DrugId:  17
1. Name:  PD-0325901
2. Groups:  Investigational
3. Description:  PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.
4. Indication:  Not Available
DrugId:  18
1. Name:  LY-3039478
2. Groups:  Investigational
3. Description:  LY3039478 has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.
4. Indication:  Not Available
DrugId:  19
1. Name:  RO-4987655
2. Groups:  Investigational
3. Description:  RO4987655 has been used in trials studying the treatment of Neoplasms.
4. Indication:  Not Available
DrugId:  20
1. Name:  9-aminocamptothecin
2. Groups:  Investigational
3. Description:  Aminocamptothecin has been used in trials studying the treatment of Lymphoma, Gastric Cancer, Ovarian Cancer, Esophageal Cancer, and Ovarian Neoplasms, among others.
4. Indication:  Not Available
DrugId:  21
1. Name:  PF-477736
2. Groups:  Investigational
3. Description:  PF-00477736 has been used in trials studying the treatment of Neoplasms.
4. Indication:  Not Available
DrugId:  22
1. Name:  PU-H71
2. Groups:  Investigational
3. Description:  PU-H71 has been used in trials studying the treatment of LYMPHOMA, Solid Tumors, Metastatic Solid Tumor, and Myeloproliferative Neoplasms (MPN).
4. Indication:  Not Available
DrugId:  23
1. Name:  Afuresertib
2. Groups:  Investigational
3. Description:  Afuresertib has been used in trials studying the treatment of Cancer and Neoplasms, Haematologic.
4. Indication:  Not Available
DrugId:  24
1. Name:  AZD-4877
2. Groups:  Investigational
3. Description:  AZD4877 has been used in trials studying the treatment of NHL, Tumors, Cancer, Lymphoma, and Neoplasms, among others.
4. Indication:  Not Available
DrugId:  25
1. Name:  Alpelisib
2. Groups:  Investigational
3. Description:  Alpelisib has been used in trials studying the treatment and basic science of Neoplasms, Solid Tumors, BREAST CANCER, 3rd Line GIST, and Rectal Cancer, among others.
4. Indication:  Not Available
